Qiagen (QGEN) Competitors

Qiagen (NYSE:QGEN) and Danaher (NYSE:DHR) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Is QGEN or DHR a better dividend stock?

Qiagen pays an annual dividend of $0.25 per share and has a dividend yield of 0.5%. Danaher pays an annual dividend of $1.28 per share and has a dividend yield of 0.6%. Qiagen pays out 14.8% of its earnings in the form of a dividend. Danaher pays out 27.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years. Danaher is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Which has higher valuation and earnings, QGEN or DHR?

Danaher has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Qiagen	$1.98B	5.59	$83.59M	$1.69	29.42
Danaher	$23.88B	6.35	$3.90B	$4.70	45.04

Do analysts prefer QGEN or DHR?

Qiagen currently has a consensus target price of $49.69, indicating a potential downside of 0.06%. Danaher has a consensus target price of $247.61, indicating a potential upside of 16.96%. Given Danaher's stronger consensus rating and higher possible upside, analysts clearly believe Danaher is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Qiagen	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.27
Danaher	0 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.85

Does the media favor QGEN or DHR?

In the previous week, Danaher had 39 more articles in the media than Qiagen. MarketBeat recorded 49 mentions for Danaher and 10 mentions for Qiagen. Danaher's average media sentiment score of 1.54 beat Qiagen's score of 1.35 indicating that Danaher is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Qiagen	7 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Danaher	47 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more risk & volatility, QGEN or DHR?

Qiagen has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, Danaher has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500.

Do institutionals and insiders believe in QGEN or DHR?

70.0% of Qiagen shares are held by institutional investors. Comparatively, 79.1% of Danaher shares are held by institutional investors. 9.0% of Qiagen shares are held by insiders. Comparatively, 11.1% of Danaher shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Is QGEN or DHR more profitable?

Qiagen has a net margin of 18.30% compared to Danaher's net margin of 14.21%. Qiagen's return on equity of 14.77% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Qiagen	18.30%	14.77%	8.87%
Danaher	14.21%	10.70%	6.85%

Summary

Danaher beats Qiagen on 15 of the 19 factors compared between the two stocks.